tiprankstipranks
Immunogen (IMGN)
NASDAQ:IMGN

ImmunoGen (IMGN) Income Statement

1,265 Followers

ImmunoGen Income Statement

Last quarter (Q3 2023), ImmunoGen's total revenue was $113.42M, an increase of 637.72% from the same quarter last year. In Q3, ImmunoGen's net income was $38.65M. See ImmunoGen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 192.70M$ 108.78M$ 69.86M$ 132.30M$ 82.27M$ 53.45M
Cost of Revenue
---$ 114.59M$ 114.52M$ 174.46M
Gross Profit
$ 198.48M$ 1.10M$ 4.90M$ 17.71M$ -32.25M$ -121.01M
Operating Expense
$ 167.20M$ -329.68M$ -194.93M$ 153.19M$ 153.01M$ 211.20M
Operating Income
$ -170.26M$ -329.68M$ -194.93M$ -20.89M$ -70.74M$ -157.76M
Net Non Operating Interest Income Expense
$ 7.05M$ 4.34M$ 4.00K$ -23.20M$ -16.97M$ -10.73M
Other Income Expense
$ -19.56M$ -103.62M$ -68.72M$ -277.00K$ -16.42M$ -361.00K
Pretax Income
$ -75.79M$ -221.71M$ -126.20M$ -44.37M$ -104.13M$ -168.84M
Tax Provision
$ -1.51M$ 1.22M----
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -65.62M$ -222.93M$ -139.30M$ -44.37M$ -104.13M$ -168.84M
Basic EPS
$ -0.31$ -0.88$ -0.68$ -0.25$ -0.70$ -1.21
Diluted EPS
$ -0.62$ -0.88$ -0.68$ -0.25$ -0.70$ -1.21
Basic Average Shares
$ 1.05B$ 253.63M$ 206.15M$ 176.15M$ 148.31M$ 139.95M
Diluted Average Shares
$ 1.06B$ 253.63M$ 206.15M$ 176.15M$ 148.31M$ 139.95M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 167.20M$ -329.68M$ -194.93M$ 153.19M$ 153.01M$ 211.20M
Net Income From Continuing And Discontinued Operation
$ -73.52M$ -222.93M$ -139.30M$ -44.37M$ -104.13M$ -168.84M
Normalized Income
$ 25.75M--$ -43.61M$ -87.12M$ -169.38M
Interest Expense
---$ 23.20M$ 16.97M$ 10.73M
EBIT
$ -75.44M$ -221.71M$ -126.15M$ -21.17M$ -87.16M$ -158.12M
EBITDA
$ -45.50M$ -223.45M$ -127.17M$ -19.07M$ -83.13M$ -150.71M
Currency in USD

ImmunoGen Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis